A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer
采用跨学科方法研究肥胖父母和儿童二人组的代谢失调和结直肠癌风险
基本信息
- 批准号:10684760
- 负责人:
- 金额:$ 110.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-16 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:3 year oldAddressAdipocytesAdipose tissueAdultAfrican AmericanAfrican American populationAge YearsAmericanAnimal ExperimentsAnimalsAnti-Inflammatory AgentsAntiinflammatory EffectBacteriaBiological AssayC-reactive proteinCancer ControlCancer InterventionCancer ModelCellsChildChronicClinical TrialsColon CarcinomaColorectal CancerCommunicationComplementComplement 2ConsumptionDietDietary InterventionDisparityEnrollmentEpidemiologyEuropeanGoalsGrantHealthHigh Fat DietHumanIncidenceInflammationInflammation MediatorsInflammatoryInfluentialsInfrastructureInsulinInsulin ResistanceInsulin-Like Growth Factor IInterleukin-6InterventionIntervention TrialLaboratory AnimalsLinkLiteratureMacrophageMalignant NeoplasmsMediatorMedicalMetabolicMetabolic dysfunctionModelingObese MiceObesityObesity associated cancerOutcomePaperParentsPathogenesisPopulationPublishingRaceRiskRoleScienceSomatomedinsSouth CarolinaStudy modelsSystemTNF geneTestingUnhealthy DietUniversitiesWorkadenomaadiponectinanticancer researchassociated symptomcancer epidemiologycancer health disparitycancer preventioncarcinogenesiscolorectal cancer progressioncolorectal cancer riskcytokinedietaryearly onset colorectal cancerepidemiology studyexperienceexperimental studyfecal transplantationgut microbesgut microbiotahigh riskhuman studyin vivoinflammatory markerintestinal barrierlifestyle interventionmicrobiomemicrobiome signaturemicrobiotamouse modelobesity in childrenpre-clinicalpreventprogramsprotective effectprotective factorsracial differenceracial identityresponsesystemic inflammatory responsetumorigenesis
项目摘要
This U01 project leverages our expertise in the epidemiology of colorectal cancer (CRC); disparities; obesity;
metabolic dysregulation, an important manifestation of inflammation; the microbiome; animal CRC models; and
lifestyle intervention trials to address the growing problem of Early-Onset CRC (EOCRC) (i.e., <50 years).
Adiposity and diet drive metabolic dysregulation. So, understanding the interaction between diet and adiposity
are key to understanding the genesis of EOCRC – and an array of other obesity-related cancers). This project
will address the absence of critical clinical trials and mechanistic studies involving lifestyle interventions for
EOCRC. We intend to address this gap; and have the transdisciplinary team representing complementary
backgrounds to do so. We focus on dietary modulation of gut microbes to reduce metaflammation and
subsequent metabolic dysfunction in obesity, with a goal of preventing EOCRC. We will perform 1) an anti-
inflammatory dietary intervention trial in dyads of adults and children at elevated risk for CRC. We also will
conduct a complementary mechanistic animal study that builds on and leverages our expertise in mechanistic
studies on obesity and CRC. This work is supported by infrastructure that we have built over the past decades
in two key centers at the University of South Carolina (UofSC): (1) Center for Colon Cancer Research (CCCR,
2002 - present – which specializes in mouse models of CRC); and (2) the Cancer Prevention and Control
Program (CPCP, 2000 - present – which specializes in the epidemiology of cancer and lifestyle intervention
trials for cancer, with a focus on cancer disparities. The two projects that comprise the proposed grant address
two Specific Aims that are represented by the human study and laboratory animal experiment: i.e. ,1: To
establish the metabolic protective effects of an anti-inflammatory diet in obese, high-risk African-
American (AA) and European-American (EA) adults and children in reducing inflammation as indicated by
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), IGF-1, Tumor Necrosis Factor alpha
(TNFα), Interleukin 6 (IL-6), and C-Reactive Protein (CRP), and a creating more favorable microbiome
signature; 2: To establish gut microbes as mediators between anti-inflammatory dietary input and
reversal of metabolic dysfunction and associated CRC risk. This complements the human study by
carrying out pre-clinical murine model studies with similar inputs (diet), intermediate endpoints (inflammation,
microbiome), and outcomes (CRC-related). We hypothesize that an anti-inflammatory dietary intervention will
reduce metabolic dysfunction and metainflammation through regulatory effects on gut microbiota.
Results from this work will address the role of metabolic dysregulation in relation to factors that are known to
be important in carcinogenesis, that therefore could have profound effects on EOCRC, have implications for
other obesity-related cancers, and have great promise for moving the field forward by addressing mechanisms
that drive large health-related disparities that consistently disfavor African Americans.
这个U 01项目利用我们在结肠直肠癌(CRC)流行病学的专业知识;差异;肥胖;
代谢失调,炎症的重要表现;微生物组;动物CRC模型;和
生活方式干预试验,以解决日益严重的早发性CRC(EOCRC)问题(即,<50年)。
肥胖和饮食驱动代谢失调。所以,了解饮食和肥胖之间的相互作用
是了解EOCRC和一系列其他肥胖相关癌症起源的关键)。这个项目
将解决缺乏关键的临床试验和机制研究,涉及生活方式干预,
EOCRC。我们打算解决这一差距;并有跨学科的团队代表互补
背景,这样做。我们专注于肠道微生物的饮食调节,以减少炎症,
肥胖症中的代谢功能障碍,目的是预防EOCRC。我们将执行1)反-
在CRC高风险成人和儿童中进行的炎症性饮食干预试验。我们也将
进行补充的机械动物研究,建立在并利用我们在机械方面的专业知识,
肥胖和CRC的研究。这项工作得到了我们在过去几十年中建立的基础设施的支持
在南卡罗来纳州大学(UofSC)的两个关键中心:(1)结肠癌研究中心(CCCR,
2002年至今-专门研究CRC小鼠模型);和(2)癌症预防和控制
计划(CPCP,2000年至今-专门研究癌症流行病学和生活方式干预
针对癌症的试验,重点关注癌症差异。包括拟议赠款地址的两个项目
人类研究和实验室动物实验代表的两个特定目的:即,1:
在肥胖的高危非洲人中建立抗炎饮食的代谢保护作用,
美国(AA)和欧洲-美国(EA)成人和儿童在减少炎症中的作用,
胰岛素抵抗(HOMA-IR)、IGF-1、肿瘤坏死因子α的稳态模型评估
(TNFα),白细胞介素6(IL-6)和C反应蛋白(CRP),以及创造更有利的微生物组
特征; 2:建立肠道微生物作为抗炎饮食输入和
逆转代谢功能障碍和相关的CRC风险。这补充了人类研究,
用相似的输入(饮食),中间终点(炎症,
微生物组)和结果(CRC相关)。我们假设,抗炎饮食干预将
通过对肠道微生物群的调节作用减少代谢功能障碍和炎症反应。
这项工作的结果将解决代谢失调的作用,与已知的因素,
在致癌作用中很重要,因此可能对EOCRC产生深远的影响,
其他肥胖相关的癌症,并有很大的希望,通过解决机制,
这导致了与健康相关的巨大差异,一直不利于非洲裔美国人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES R HEBERT其他文献
JAMES R HEBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES R HEBERT', 18)}}的其他基金
A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer
采用跨学科方法研究肥胖父母和儿童二人组的代谢失调和结直肠癌风险
- 批准号:
10505332 - 财政年份:2022
- 资助金额:
$ 110.47万 - 项目类别:
Expand NCI-Supported Community Outreach Capacity
扩大 NCI 支持的社区外展能力
- 批准号:
8759438 - 财政年份:2013
- 资助金额:
$ 110.47万 - 项目类别:
Research Supplements to Promote Diversity in Health-Related Program
促进健康相关项目多样性的研究补充
- 批准号:
8759457 - 财政年份:2013
- 资助金额:
$ 110.47万 - 项目类别:
South Carolina Cancer Disparities Community Network -- II
南卡罗来纳州癌症差异社区网络 -- II
- 批准号:
8911967 - 财政年份:2010
- 资助金额:
$ 110.47万 - 项目类别:
South Carolina Cancer Disparities Community Network -- II
南卡罗来纳州癌症差异社区网络 -- II
- 批准号:
8538767 - 财政年份:2010
- 资助金额:
$ 110.47万 - 项目类别:
South Carolina Cancer Disparities Community Network -- II
南卡罗来纳州癌症差异社区网络 -- II
- 批准号:
8730838 - 财政年份:2010
- 资助金额:
$ 110.47万 - 项目类别:
South Carolina Cancer Disparities Community Network -- II
南卡罗来纳州癌症差异社区网络 -- II
- 批准号:
8323608 - 财政年份:2010
- 资助金额:
$ 110.47万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 110.47万 - 项目类别:
Research Grant